Status | Study |
Completed |
Study Name: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV-I-Associated Myelopathy Date: 2011-04-25 Interventions: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Study Name: Lenalidomide in HTLV-1 Adult T-Cell Leukemia Condition: Adult T Cell Leukemia/Lymphoma Date: 2011-01-10 Interventions: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc |
Enrolling by invitation |
Study Name: Evaluation of InnoLIA HTLV I/II Score Condition: Human T-Lymphotrophic Virus Type I and/or Type II Date: 2010-06-22 Interventions: Device: InnoLIA HTLV I/II Score line immunoassay This intervention consists of testing a residual serum |
Terminated |
Study Name: Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma Condition: Lymphoma Precancerous/Nonmalignant Condition Date: 2009-02-28 Interventions: Biological: PEG-interferon alfa-2b |
Terminated |
Study Name: The HAM Infliximab Study Condition: HTLV-I-associated Myelopathy Date: 2009-01-14 Interventions: Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Completed |
Study Name: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV I Associated Myelopathy Date: 2008-10-15 Interventions: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Terminated |
Study Name: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condition: HTLV-I-Associated Myelopathy Date: 2007-08-20 Interventions: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Recruiting |
Study Name: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condition: HTLV-1 Date: 2006-07-12 Interventions: Drug: Hu MiK-Beta-1 |
Completed |
Study Name: Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica Condition: HTLV-I Date: 2006-06-19 |
Completed |
Study Name: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Condition: HTLV-I Date: 2006-06-19 |